bio-rad laboratories (nyse: bio and biob) offers a broad range of innovative tools and services to the life science research and clinical diagnostics markets. founded in 1952, bio-rad has a global team of more than 7,600 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. throughout its existence, bio-rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more. based in hercules, ca, bio-rad has operations worldwide.
Financial Statements
- Click here to download Bio-Rad Laboratories Inc.'s Income Statement
- Click here to download Bio-Rad Laboratories Inc.'s Balance Sheet
- Click here to download Bio-Rad Laboratories Inc.'s Statement of Cash Flows
Key Info
- Industry: Analytical Laboratory Instrument Manufacturing
- Sector: Manufacturing
- CEO Name: Norman Schwartz
Key Statistics
- Stock Price: $358.45
- Dividend Yield: 0%
- Market Capitalization: $10,405,178,797
- Shares Outstanding: 24,004,023
- Number of Employees: 8,073
- Trailing 12-Month EPS: $-14.31
- Trailing 12-Month DPS: $0
- Payout Ratio: -0.0%
Important Dates
- Next Earnings Date: 2023-11-02
- Next Ex-Dividend Date:
Price Trends
- Current Stock Price: $358.45
- 52-week high: $509.62
- 52-week low: $344.63
- 200-day moving average: $403.4
- 50-day moving average: $374.07
Performance
- 1-Month Price Return: -9.4%
- 3-Month Price Return: -4.5%
- 6-Month Price Return: -24.1%
- 1-Year Price Return: -14.3%
- 2-Year Price Return: -52.2%
- 5-Year Price Return: 14.5%
Visit the Passiv Stock Directory
Data provided by IEX Cloud
For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast